Willis Johnson & Associates’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.7K | Hold |
17,500
| – | – | ﹤0.01% | 164 |
|
|
2025
Q1 | $33.6K | Hold |
17,500
| – | – | ﹤0.01% | 163 |
|
|
2024
Q4 | $33.3K | Hold |
17,500
| – | – | ﹤0.01% | 154 |
|
|
2024
Q3 | $23.1K | Hold |
17,500
| – | – | ﹤0.01% | 167 |
|
|
2024
Q2 | $17.9K | Hold |
17,500
| – | – | ﹤0.01% | 154 |
|
|
2024
Q1 | $32K | Hold |
17,500
| – | – | ﹤0.01% | 157 |
|
|
2023
Q4 | $21.7K | Hold |
17,500
| – | – | ﹤0.01% | 138 |
|
|
2023
Q3 | $20K | Buy |
+17,500
| New | +$20K | ﹤0.01% | 125 |
|